NASDAQ:CPHD - Cepheid Stock Price, Forecast & News Notice: This company has been marked as potentially delisted and may not be actively trading. Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Cepheid Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add Add Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage Volume1.25 million shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABetaN/A ProfileEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Cepheid is a molecular diagnostics company. The Company develops, manufactures and markets fully-integrated systems for testing in the Clinical and Non-Clinical markets. The Company's systems enable molecular testing for organisms and genetic-based diseases by automating otherwise complex manual laboratory procedures. The Company's systems integrate these steps and analyze biological samples in test cartridges. Read More… Industry, Sector and Symbol Stock Exchange NASDAQ Industry N/A Sub-IndustryBiotechnology SectorN/A Current SymbolNASDAQ:CPHD Previous Symbol CUSIP15670R10 CIK1037760 Webhttp://www.cepheid.com/ Phone+1-408-5414191Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding SharesN/AMarket CapN/A Next Earnings DateN/A OptionableNot Optionable Receive CPHD News and Ratings via Email Sign-up to receive the latest news and ratings for CPHD and its competitors with MarketBeat's FREE daily newsletter. Your 401(k) or IRA account could be in double-trouble in 2020! With a slowing global economy and the uncertainty of a national election looming, it's time to PLAY DEFENSE with your hard-earned money. Employ a winning strategy for wealth protection and portfolio diversification to avoid the coming rush of economic risk. Cepheid (NASDAQ:CPHD) Frequently Asked Questions What is Cepheid's stock symbol? Cepheid trades on the NASDAQ under the ticker symbol "CPHD." How were Cepheid's earnings last quarter? Cepheid (NASDAQ:CPHD) released its earnings results on Thursday, July, 28th. The scientific and technical instruments company reported $0.05 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.14) by $0.19. The scientific and technical instruments company earned $146 million during the quarter, compared to analyst estimates of $145.82 million. Cepheid's quarterly revenue was up 10.2% on a year-over-year basis. During the same quarter in the previous year, the firm earned ($0.06) EPS. View Cepheid's Earnings History. Has Cepheid been receiving favorable news coverage? Media stories about CPHD stock have trended somewhat positive on Monday, InfoTrie reports. The research firm identifies negative and positive media coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Cepheid earned a coverage optimism score of 1.7 on InfoTrie's scale. They also gave news stories about the scientific and technical instruments company a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an impact on the company's share price in the near future. View News Stories for Cepheid. Who are some of Cepheid's key competitors? Some companies that are related to Cepheid include Amgen (AMGN), Gilead Sciences (GILD), Celgene (CELG), Vertex Pharmaceuticals (VRTX), Biogen (BIIB), Regeneron Pharmaceuticals (REGN), Alexion Pharmaceuticals (ALXN), Seattle Genetics (SGEN), Incyte (INCY), BioMarin Pharmaceutical (BMRN), Alnylam Pharmaceuticals (ALNY), EXACT Sciences (EXAS), Neurocrine Biosciences (NBIX), Ionis Pharmaceuticals (IONS) and Exelixis (EXEL). What other stocks do shareholders of Cepheid own? Based on aggregate information from My MarketBeat watchlists, some companies that other Cepheid investors own include Intel (INTC), NVIDIA (NVDA), QUALCOMM (QCOM), Alibaba Group (BABA), Wells Fargo & Co (WFC), Celgene (CELG), Gilead Sciences (GILD), GenMark Diagnostics (GNMK), Intercept Pharmaceuticals (ICPT) and Illumina (ILMN). What is Cepheid's official website? The official website for Cepheid is http://www.cepheid.com/. How can I contact Cepheid? Cepheid's mailing address is 904 E Caribbean Dr, SUNNYVALE, CA 94089-1189, United States. The scientific and technical instruments company can be reached via phone at +1-408-5414191. MarketBeat Community Rating for Cepheid (NASDAQ CPHD)Community Ranking: 2.5 out of 5 ( )Outperform Votes: 521 (Vote Outperform)Underperform Votes: 502 (Vote Underperform)Total Votes: 1,023MarketBeat's community ratings are surveys of what our community members think about Cepheid and other stocks. Vote "Outperform" if you believe CPHD will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CPHD will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 1/20/2020 by MarketBeat.com StaffFeatured Article: What are the benefits of a portfolio tracker?